Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis

Area of Science:

• Cell Biology
• Molecular Biology
• Pathology

Background:

• Mitogen-activated protein kinase (MAPK) phosphatase 5 (MKP-5) negatively regulates p38 MAPK and JNK signaling pathways.
• MKP-5 deficiency improves muscle repair and reduces fibrosis in muscular dystrophy models.
• The role of MKP-5 in pulmonary fibrosis remains unexplored.

Purpose of the Study:

• To investigate the role of MKP-5 in the development of lung fibrosis.
• To determine if MKP-5 influences transforming growth factor-β1 (TGF-β1) signaling in lung fibroblasts.
• To assess MKP-5 as a potential therapeutic target for pulmonary fibrosis.

Main Methods:

• Utilized a bleomycin-induced mouse model of pulmonary fibrosis.
• Assessed lung fibrosis markers including hydroxyproline levels and fibrogenic gene expression.
• Analyzed macrophage polarization and fibroblast differentiation.
• Investigated TGF-β1 signaling pathways, including Smad phosphorylation and Smad7 levels, in lung fibroblasts.
• Examined MKP-5 expression in idiopathic pulmonary fibrosis (IPF) patient-derived cells.

Main Results:

• MKP-5-deficient mice were protected from bleomycin-induced lung fibrosis.
• Reduced hydroxyproline levels and fibrogenic gene expression were observed in MKP-5-deficient mice.
• MKP-5 deficiency promoted M1-macrophage polarization.
• Inhibition of TGF-β1 profibrotic effects was observed in MKP-5-deficient lung fibroblasts.
• MKP-5 deficiency led to enhanced p38 MAPK activity, impaired Smad3 phosphorylation, increased Smad7 levels, and attenuated myofibroblast differentiation.
• MKP-5 expression was elevated in IPF-derived lung fibroblasts.

Conclusions:

• MKP-5 plays a critical role in promoting lung fibrosis.
• MKP-5 is coupled with TGF-β1 signaling in the pathogenesis of lung fibrosis.
• MKP-5 inhibition represents a potential therapeutic strategy for treating human pulmonary fibrosis.